CHGCY
Price:
$20.3
Market Cap:
$10.34T
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutic...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-08-03
Stock Exchange
PNK
Ticker
CHGCY
Dividends are a key part of long-term returns for investors, and Chugai Pharmaceutical Co., Ltd. (CHGCY) has a track record worth reviewing. Looking at dividend history for CHGCY gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2023-12-28
Dividend Yield
0.65%
Annual Dividend
$0.13
P/E Ratio
26.71
Payout Ratio
0.37
Dividend per Share
$0.13
EPS
0.76
Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
---|---|---|---|---|
2023-12-28 | $0.13216 | $0.13216 | 2024-04-01 | |
2023-06-29 | $0.13725 | $0.13725 | 2023-09-14 | |
2022-12-29 | $0.1504 | $0.1504 | 2023-04-14 | 2022-12-06 |
2022-06-29 | $0.13693 | $0.13693 | 2022-09-14 | |
2021-12-29 | $0.18867 | $0.18867 | 2022-04-14 | |
2021-06-28 | $0.13651 | $0.13651 | 2021-09-14 | |
2020-12-29 | $0.13797 | $0.13797 | 2021-04-07 | |
2020-06-26 | $1.4231 | $0.11859 | 2020-09-14 | |
2019-12-27 | $1.7105 | $0.14255 | 2020-04-15 | |
2019-06-27 | $0.9046 | $0.075381 | 2019-06-26 | |
2018-12-27 | $0.9929 | $0.082745 | 2019-04-15 |
The table below shows Chugai Pharmaceutical Co., Ltd. (CHGCY) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Chugai Pharmaceutical Co., Ltd. (CHGCY) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
Stock name | Dividend yield |
---|---|
Merck & Co., Inc. (MRK) | 0.03% |
Johnson & Johnson (JNJ) | 0.02% |
Pfizer Inc. (PFE) | 0.07% |
Astellas Pharma Inc. (ALPMF) | 0.05% |
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) | 0.00% |
Otsuka Holdings Co., Ltd. (OTSKF) | 0.01% |
AstraZeneca PLC (NVS) | 0.07% |
GSK plc (AZN) | 0.02% |
Roche Holding AG (GSK) | 0.05% |
Bristol-Myers Squibb Company (RHHBY) | 0.04% |
Horizon Therapeutics Public Limited Company (BMY) | 0.04% |
Sanofi (GILD) | 0.03% |
(SNY) | 0.03% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Chugai Pharmaceutical Co., Ltd. (CHGCY) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is CHGCY’s dividend yield?
What is the difference between regular and special dividends?
Has CHGCY increased its dividends over time?
Why might dividend history data be delayed?
How often does CHGCY pay dividends?
What factors impact CHGCY's dividend payments?
Can dividends change over time?
What is CHGCY’s next dividend date?